- Japan’s childhood hepatitis cases of unknown etiology rise to 31
- No need COVID-19 vaccination and quarantine when entering these countries
- New strategy for tumor immunotherapy: Lactate metabolism in Treg cells
- Global tumor new drug research and development report released
- Stem cells can reverse premature ovarian failure
- Can natural killer cells-NK cells also fight against COVID-19?
Brazil intends to purchase extra 20 million China’s COVID-19 vaccines
Brazil intends to purchase extra 20 million China’s COVID-19 vaccines. Brazil has more than 50,000 new confirmed cases in a single day and plans to buy more COVID-19 vaccines for much more serious situation.
As of February 5, local time, Brazil had 50,872 new confirmed cases of new coronavirus pneumonia in a single day, with a total of 9,447,165 confirmed cases, 1,239 new deaths, and a total of 230,034 deaths.
According to an exclusive report by Reuters on February 5, the Governor of Brazil’s Sao Paulo State, Joo Doria, revealed in an interview on the 4th that Brazil is purchasing 20 million additional doses of the COVID-19 vaccine developed by China’s Kexing. Have a discussion. Last month, Brazil signed an agreement with the country’s Butantan Institute to purchase 100 million doses of the Kellyph Covid-19 vaccine. Reuters commented that this additional purchase shows that Brazil has confidence in China’s COVID-19 vaccine.
More than 16,000 new confirmed cases in Russia in a single day Brazil Ministry of Health intends to purchase Russian-made COVID-19 vaccine
According to the latest data released on the 5th on the official website of the Russian COVID-19 virus epidemic prevention, Russia added 16,688 new confirmed cases of COVID-19 pneumonia, a total of 3,934,606 confirmed cases, 527 new COVID-19 pneumonia deaths, and a total of 75,732 deaths.
According to news from the Russian Satellite Network on the 5th, the Ministry of Health of Brazil announced that the country intends to purchase Russia’s “Satellite-V” COVID-19 vaccine. At present, Brazil has issued emergency use authorizations to AstraZeneca in the United Kingdom and vaccines produced by Kexing Biological in China.
(source:internet, reference only)